Drugs for the Heart
Lionel H. Opie, Bernard J. Gersh
Elsevier Saunders, 2005 - Medical - 437 pages
The new 6th Edition continues to be the definitive pocket-sized guide on the "hows" and "whys" of cardiovascular drugs. It provides in-depth information on all of the drug classes used to treat heart disease, and covers drug use, new drug classes, drug use for single and multiple problem management, and more. A user-friendly organization speed readers to the information they need, and dynamic new full-color drawings illustrate key pharmacological and physiological actions. The new edition includes access to the companion website, which offers bi-annual content updates to keep you current with new drugs, indications and leading trials. The website also has the feature of fully searchable text to access book content via drug, disease or drug action.
61 pages matching randomized in this book
Results 1-3 of 61
What people are saying - Write a review
We haven't found any reviews in the usual places.
ACE inhibitors activity acute myocardial infarction adenosine agents aldosterone amiodarone amlodipine angina angiotensin-II antiarrhythmic drugs anticoagulation antihypertensive ARBs arrhythmias aspirin atenolol atrial fibrillation benefit blockers blood pressure captopril cardiac cardiovascular cardioversion carvedilol CCBs cholesterol Circulation clinical clopidogrel Coll Cardiol combination congestive heart failure contraindicated coronary artery decrease diabetes digoxin diltiazem diuretic dofetilide dose dysfunction efficacy elderly enalapril Engl enzyme furosemide heart disease hemodynamic heparin hepatic hydrochlorothiazide hypertension hypokalemia hypotension IAMA ibutilide increased infusion inhibition inotropic interaction intravenous ischemic Lancet LDL-C left ventricular levels LH Opie lipid long-term low-dose major metabolism metoprolol mg daily mortality myocardial infarction nifedipine nitrates oral outcome P-blockade P-blockers package insert patients peripheral platelet postinfarct potassium prevention propafenone propranolol quinidine randomized receptor reduced renal risk factors side effects sodium sotalol statins stroke supraventricular systolic therapy thiazide tion torsades treatment trial unstable angina vascular vasodilation verapamil versus warfarin